H.R.1142 - To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes. (119th Congress)
Summary
H.R.1142 aims to amend the Public Health Service Act, directing the Secretary of Health and Human Services (HHS) to establish drug adherence guidelines. The goal is to achieve 90% adherence for Medicare Part B and D drugs. The guidelines will incorporate artificial intelligence and machine learning technologies and promote the use of generic and biosimilar drugs.
Expected Effects
The bill, if enacted, would lead to the creation of national drug adherence guidelines. These guidelines would likely influence prescribing practices and patient behavior regarding medication adherence. The use of AI and promotion of generics/biosimilars could also impact healthcare costs and innovation.
Potential Benefits
- Improved patient health outcomes through better medication adherence.
- Potential cost savings for Medicare and patients by promoting generic and biosimilar drugs.
- Enhanced efficiency in healthcare delivery through the use of AI and machine learning.
- Better data collection and analysis related to drug adherence, leading to more informed healthcare policies.
- Reduction in hospitalizations and other adverse events due to non-adherence.
Most Benefited Areas:
Potential Disadvantages
- Potential for increased government oversight and intervention in healthcare decisions.
- Concerns about data privacy and security related to the use of AI and machine learning in healthcare.
- Possible resistance from patients or healthcare providers to the guidelines.
- Unintended consequences of strict adherence targets, such as over-medication or reduced patient autonomy.
- The cost of implementing and maintaining the AI and machine learning infrastructure.
Constitutional Alignment
The bill appears to align with the general welfare clause of the Constitution, as it aims to improve public health and reduce healthcare costs. Specifically, the preamble states the Constitution is intended to "promote the general Welfare". The bill falls under Congress's power to regulate interstate commerce, as it affects the pharmaceutical industry and healthcare services. However, potential privacy concerns related to data collection and AI implementation could raise questions regarding the Fourth Amendment's protection against unreasonable searches and seizures.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).